Carbopyronone compounds useful as diagnostic adjuvants

US10018617B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10018617-B2
Application numberUS-201515304800-A
CountryUS
Kind codeB2
Filing dateMay 15, 2015
Priority dateMay 16, 2014
Publication dateJul 10, 2018
Grant dateJul 10, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described herein are fluorescent compounds and methods and comprising these compounds. The compounds disclosed herein are carbopyronine reagents that fluoresce in the red portion of the UV/VIS spectrum and provide bright fluorescence intensity, uniform cell staining, and good retention within live cells as well as low toxicity toward cells.

First claim

Opening claim text (preview).

We claim: 1. A method for tracking cell proliferation and differentiation, the method comprising the steps of: a) incubating a mixture of cells and a compound of structural formula (II): or a pharmaceutically acceptable salt thereof, wherein R 12 and R 13 are each independently H, C 1 -C 6 substituted alkyl, -L-R x , or -L-S c ; R 2 is carboxyl, -L-R x , or -L-S c ; R 3 , R 4 , R 5 and R 6 are each independently H or halogen; R 7 and R 9 are each C 1 -C 6 alkyl, C 1 -C 6 substituted alkyl, sulfoalky, -L-R x , or -L-S c ; R 11 , R 14 , R 17 , R 18 , R 19 , R 20 , R 21 and R 22 are each H; L is a linker; R x is an acrylamide, a carboxylic acid, an activated ester of a carboxylic acid, an acyl azide, an acyl halide, hydroxy, an aldehyde, an alkyl halide, a sulfonate, an amine, an anhydride, an aniline, an aryl halide, an azide, an aziridine, a boronate, a carbodiimide, a diazoalkane, an epoxide, a glycol, a haloacetamide, a halotriazine, a hydrazine, a hydroxylamine, an imido ester, an isothiocyanate, a ketone, a maleimide, a sulfonyl halide, a thiol group, a succinimidyl ester (SE), a sulfodichlorophenyl (SDP) ester, a sulfotetrafluorophenyl (STP) ester, a tetrafluorophenyl (TFP) ester, a pentafluorophenyl (PFP) ester, a nitrilotriacetic acid (NTA), an aminodextran, and a cyclooctyne-amine; and S c is a solid support, a tyramide, an amino acid, a peptide, a protein, a monosaccharide, a polysaccharide, an ion-complexing moiety, a nucleotide, an oligonucleotide, a nucleic acid, a hapten, a drug, a toxin, a lipid, a phospholipid, a lipoprotein, a lipopolysaccharide, a liposome, a lipophilic polymer, a PEG group, a non-biological organic polymer, a polymeric microparticle, an animal cell, a plant cell, a bacterium, a yeast, or a virus; b) providing a stimulus to the mixture to elicit a fluorescent signal; and c) analyzing the stimulated mixture. 2. The method according to claim 1 , further comprising a second compound excitable at a different wavelength than the compound of structural formula. 3. The method according to claim 2 , wherein the second compound is CFDA-SE or GFP. 4. The method according to claim 1 , wherein for the compound of structural formula R 12 and R 13 are each methyl. 5. The method according to claim 1 , wherein the compound is selected from the group consisting of:

Assignees

Inventors

Classifications

  • C07D471/04Primary

    Ortho-condensed systems · CPC title

  • Pyronines {; Xanthon, thioxanthon, selenoxanthan, telluroxanthon dyes} · CPC title

  • for testing toxicity · CPC title

  • the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups · CPC title

  • against CD4 · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10018617B2 cover?
Described herein are fluorescent compounds and methods and comprising these compounds. The compounds disclosed herein are carbopyronine reagents that fluoresce in the red portion of the UV/VIS spectrum and provide bright fluorescence intensity, uniform cell staining, and good retention within live cells as well as low toxicity toward cells.
Who is the assignee on this patent?
Life Technologies Corp
What technology area does this patent fall under?
Primary CPC classification C07D471/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).